[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @mtheory11bio Chris Carper Chris Carper posts on X about $qure, $abvx, abs, $drug the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::1555606459/interactions)  - X Week XXXXXX +103% - X Month XXXXXX +5.70% - X Months XXXXXXX -XX% - X Year XXXXXXX -XX% ### Mentions: X [#](/creator/twitter::1555606459/posts_active)  ### Followers: XXXXX [#](/creator/twitter::1555606459/followers)  - X Week XXXXX +0.29% - X Month XXXXX +1.50% - X Months XXXXX +2.90% - X Year XXXXX +8.70% ### CreatorRank: XXXXXXX [#](/creator/twitter::1555606459/influencer_rank)  ### Social Influence [#](/creator/twitter::1555606459/influence) --- **Social category influence** [cryptocurrencies](/list/cryptocurrencies) [stocks](/list/stocks) [currencies](/list/currencies) [technology brands](/list/technology-brands) [finance](/list/finance) **Social topic influence** [$qure](/topic/$qure) #2, [$abvx](/topic/$abvx) #71, [abs](/topic/abs) #488, [$drug](/topic/$drug) #1, [$iobt](/topic/$iobt) #1, [$atyr](/topic/$atyr) #10, [$vyne](/topic/$vyne) #3, [$mreo](/topic/$mreo) #2, [$rare](/topic/$rare) #18, [$vktx](/topic/$vktx) #18 **Top assets mentioned** [SuperRare (RARE)](/topic/$rare) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [AstraZeneca PLC (AZN)](/topic/$azn) [PTC Therapeutics, Inc. (PTCT)](/topic/$ptct) ### Top Social Posts [#](/creator/twitter::1555606459/posts) --- Top posts by engagements in the last XX hours "Im adding a few for July / August that look interesting: $PRAX Vormatrigine FOS / epilepsy $IXHL IHL-42X OSA $ABVX obefazimod UC $ELDN Tegoprubart kidney transplant"  [@mtheory11bio](/creator/x/mtheory11bio) on [X](/post/tweet/1947351033623036335) 2025-07-21 17:40:41 UTC 4861 followers, 3312 engagements "I get that investors are nervous about single arm trials being adequate for approval after the $REPL CRL but thats why $QURE agreed with the FDA on a SAP using a matched external control. If the bar for approval has been lifted $QURE is still above it in my opinion"  [@mtheory11bio](/creator/x/mtheory11bio) on [X](/post/tweet/1947623998184989170) 2025-07-22 11:45:20 UTC 4861 followers, 5407 engagements "$ABVX making one of those somebody knows something moves this morning. Well know soon if thats actually the case"  [@mtheory11bio](/creator/x/mtheory11bio) on [X](/post/tweet/1945454851204272342) 2025-07-16 12:05:55 UTC 4861 followers, 4862 engagements "Congrats to everyone involved with $ABVX a lot of smart people gave a heads up recently regarding the potential and likelihood of success. If you ever believe investing in biotech is easy take a look at the 25mg results in ABTECT-1 and X despite being equally designed trials"  [@mtheory11bio](/creator/x/mtheory11bio) on [X](/post/tweet/1947875168635715736) 2025-07-23 04:23:24 UTC 4861 followers, 2465 engagements "@DragonMaxGoku @plainyogurt21 @AB1001_disciple @MelvinRiskMgmt @DesertDweller93 They need to be matched for the patients they enroll. $PTCT used ENROLL-HD for their XX month update and $QURE used TRACK-HD / TRACK-ON / PREDICT-HD for their XX month update. The patients and results were pretty similar at XXX vs XXX decline in cUHDRS"  [@mtheory11bio](/creator/x/mtheory11bio) on [X](/post/tweet/1945955293843648969) 2025-07-17 21:14:30 UTC 4861 followers, XXX engagements "Some readouts in Q3 that Im looking forward to: $RARE / $MREO ORBIT IA2 OI $QURE AMT-130 3-year Huntingtons $VYNE VYN201 Vitiligo $VKTX oral VK2735 obesity $ATYR EFZO-FIT pulmonary sarc $IOBT IOB-013/KN-D18 melanoma $AZN AZD3427 Group X PH $DRUG BMB-101 Abs epilepsy / DEE"  [@mtheory11bio](/creator/x/mtheory11bio) on [X](/post/tweet/1939687129602519479) 2025-06-30 14:07:03 UTC 4861 followers, 38K engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Chris Carper posts on X about $qure, $abvx, abs, $drug the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.
Social category influence cryptocurrencies stocks currencies technology brands finance
Social topic influence $qure #2, $abvx #71, abs #488, $drug #1, $iobt #1, $atyr #10, $vyne #3, $mreo #2, $rare #18, $vktx #18
Top assets mentioned SuperRare (RARE) Viking Therapeutics, Inc (VKTX) AstraZeneca PLC (AZN) PTC Therapeutics, Inc. (PTCT)
Top posts by engagements in the last XX hours
"Im adding a few for July / August that look interesting: $PRAX Vormatrigine FOS / epilepsy $IXHL IHL-42X OSA $ABVX obefazimod UC $ELDN Tegoprubart kidney transplant" @mtheory11bio on X 2025-07-21 17:40:41 UTC 4861 followers, 3312 engagements
"I get that investors are nervous about single arm trials being adequate for approval after the $REPL CRL but thats why $QURE agreed with the FDA on a SAP using a matched external control. If the bar for approval has been lifted $QURE is still above it in my opinion" @mtheory11bio on X 2025-07-22 11:45:20 UTC 4861 followers, 5407 engagements
"$ABVX making one of those somebody knows something moves this morning. Well know soon if thats actually the case" @mtheory11bio on X 2025-07-16 12:05:55 UTC 4861 followers, 4862 engagements
"Congrats to everyone involved with $ABVX a lot of smart people gave a heads up recently regarding the potential and likelihood of success. If you ever believe investing in biotech is easy take a look at the 25mg results in ABTECT-1 and X despite being equally designed trials" @mtheory11bio on X 2025-07-23 04:23:24 UTC 4861 followers, 2465 engagements
"@DragonMaxGoku @plainyogurt21 @AB1001_disciple @MelvinRiskMgmt @DesertDweller93 They need to be matched for the patients they enroll. $PTCT used ENROLL-HD for their XX month update and $QURE used TRACK-HD / TRACK-ON / PREDICT-HD for their XX month update. The patients and results were pretty similar at XXX vs XXX decline in cUHDRS" @mtheory11bio on X 2025-07-17 21:14:30 UTC 4861 followers, XXX engagements
"Some readouts in Q3 that Im looking forward to: $RARE / $MREO ORBIT IA2 OI $QURE AMT-130 3-year Huntingtons $VYNE VYN201 Vitiligo $VKTX oral VK2735 obesity $ATYR EFZO-FIT pulmonary sarc $IOBT IOB-013/KN-D18 melanoma $AZN AZD3427 Group X PH $DRUG BMB-101 Abs epilepsy / DEE" @mtheory11bio on X 2025-06-30 14:07:03 UTC 4861 followers, 38K engagements
/creator/x::mtheory11bio